# Lipocine Inc.: Form 8-K, filed Oct 23, 2024

- Company: [Lipocine Inc.](/companies/lpcn.md) (CIK 1535955)
- Form: 8-K
- Filed: 2024-10-23
- Accepted by EDGAR: Oct 22, 2024, 18:38 ET
- Period: 2024-10-22
- Accession: 0001493152-24-042117
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1535955/000149315224042117/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1535955/000149315224042117/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1535955/000149315224042117/form8-k.htm

Filed Oct 23, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-042117. Last ingested by Listed: Nov 5, 2026, 12:44 ET. No prices; not investment advice.